Mario Cardozo from 579 Miramar Ave, San Francisco, CA 94112, age 65, Phone: 4153333340

Resumes

Chief Executive Officer Heavenly Touch Interiors

view source

Location:

San Francisco, CA

Industry:

Architecture & Planning

Work:

Cubic Figures Jan 1990 - Apr 1992
Personal Assistant
Jan 1990 - Apr 1992
Chief Executive Officer Heavenly Touch Interiors

Mario Cardozo

view source

Work:

Cubic Figures Jan 1990 - Apr 1992
Personal Assistant

Royal College Of Art

view source

Location:

San Francisco, CA

Industry:

Architecture & Planning

Work:

Royal College of Art

Education:

Royal College of Art
Bachelor of Architecture, Bachelors

Principal Scientist

view source

Location:

San Francisco, CA

Industry:

Biotechnology

Work:

Amgen
Principal Scientist

Skills:

Biotechnology Industry

Director Of Computational Chemistry

view source

Location:

San Francisco, CA

Industry:

Pharmaceuticals

Work:

Nurix, Inc.
Director of Computational Chemistry
Md Anderson Cancer Center Mar 2014 - Oct 2014
Senior Research Scientist
Amgen Aug 2004 - Dec 2013
Principal Scientist
Tularik 2002 - 2004
Principal Scientist
Boehringer Ingelheim 1996 - 2002
Princip[Al Scientist

Education:

University of Illinois at Chicago 1989 - 1992
University of Buenos Aires 1983 - 1988
Doctorates, Doctor of Philosophy, Pharmacy Universidad Nacional De Córdoba 1979 - 1983
Bachelors, Bachelor of Science, Chemistry, Organic Chemistry

Skills:

Drug Design
Drug Discovery
Computational Chemistry
Medicinal Chemistry
Molecular Modeling
Drug Development
Cheminformatics
Adme
Lead Change
Protein Chemistry
Drug Metabolism
Organic Chemistry
High Throughput Screening
Lc Ms
Organic Synthesis
Gpcrs
Pharmacology
Parallel Synthesis
Pharmaceutical Research
Heterocyclic Chemistry

Mario Ivan Guarnizo Cardozo

view source

Mario Cardozo

view source

Wikipedia

Eduardo Acevedo

view source

Eduardo Mario Acevedo Cardozo (born September 25, 1959 in Montevideo) is a retired football defender and current manager from Uruguay. He obtained a total

Us Patents

Antiinflammation Agents
view source
US Patent:

7199119, Apr 3, 2007
Filed:

Sep 19, 2003
Appl. No.:

10/666857
Inventors:

Simon A. Burkitt - Kirkby-in-Ashfield, GB
Mario G. Cardozo - San Francisco CA, US
Timothy D. Cushing - Pacifica CA, US
Michael R. DeGraffenreid - San Francisco CA, US
Christopher N. Farthing - Macclesfield, GB
Xiaolin Hao - Foster City CA, US
Juan C. Jaen - Burlingame CA, US
XianYun Jiao - San Mateo CA, US
David J. Kopecky - San Francisco CA, US
Marc Labelle - Burlingame CA, US
Sarah E. Lively - Congleton, GB
Dustin L. McMinn - Pacifica CA, US
Sven P. Rasmussen - Congleton, GB
Youngsook Shin - San Mateo CA, US
Marie-Louise Smith - Half Moon Bay CA, US
Andrew Smith - Macclesfield, GB
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

A61K 31/5377
A61K 31/4365
C07D 413/14
C07D 471/04
US Classification:

5142338, 546114, 514301, 544127
Abstract:

Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic, infectious and cell proliferative diseases or conditions are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, metabolism, infection and cell proliferation. The subject compounds contain a fused heterobicyclic ring.

Pyrimidine Derivatives Useful As Inhibitors Of Pkc-Theta
view source
US Patent:

7550473, Jun 23, 2009
Filed:

Sep 3, 2004
Appl. No.:

10/933635
Inventors:

Mario G. Cardozo - San Francisco CA, US
Derek Cogan - Sandy Hook CT, US
Charles Lawrence Cywin - Bethel CT, US
George Dahmann - Attenweiler, DE
Darren DiSalvo - New Milford CT, US
John David Ginn - New Milford CT, US
Denice M. Spero - West Redding CT, US
Erick Richard Roush Young - Danbury CT, US
Assignee:

Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
Boehringer Ingelheim Pharma GmbH & Co. KG - Ingelheim
International Classification:

C07D 239/42
A61K 31/505
US Classification:

514275, 544323
Abstract:

Disclosed are novel compounds of formula (I):.

Antiinflammation Agents
view source
US Patent:

7635695, Dec 22, 2009
Filed:

Feb 21, 2007
Appl. No.:

11/709895
Inventors:

Simon A. Burkitt - Kirkby-in-Ashfield, GB
Mario G. Cardozo - San Francisco CA, US
Timothy D. Cushing - Pacifica CA, US
Michael R. DeGraffenreid - San Francisco CA, US
Christopher N. Farthing - Macclesfield, GB
Xiaolin Hao - Foster City CA, US
Juan C. Jaen - Burlingame CA, US
Xian Yun Jiao - San Mateo CA, US
David J. Kopecky - San Francisco CA, US
Marc Labelle - Burlingame CA, US
Sarah E. Lively - Congleton, GB
Dustin L. McMinn - Pacifica CA, US
Sven P. Rasmussen - Congleton, GB
Youngsook Shin - San Mateo CA, US
Marie-Louise Smith - Half Moon Bay CA, US
Andrew Smith - Macclesfield, GB
Assignee:

Amgen Inc. - South San Francisco CA
International Classification:

A61K 31/5377
A61K 31/4365
C07D 413/14
C07D 495/04
US Classification:

5142338, 514301, 544127, 546114
Abstract:

Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic, infectious and cell proliferative diseases or conditions are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, metabolism, infection and cell proliferation. The subject compounds contain a fused heterobicyclic ring.

Triazole Compounds And Uses Related Thereto
view source
US Patent:

7683059, Mar 23, 2010
Filed:

Sep 5, 2006
Appl. No.:

10/587846
Inventors:

Mario G. Cardozo - San Francisco CA, US
Jay P. Powers - Pacifica CA, US
Hiroyuki Goto - Takatsuki, JP
Kazuhito Harada - Osaka, JP
Katsuaki Imamura - Tokyo, JP
Makoto Kakutani - Takatsuki, JP
Isamu Matsuda - Tokyo, JP
Yasuhiro Ohe - Tokyo, JP
Shinji Yata - Tokyo, JP
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

A61K 31/4196
A61K 31/5377
C07D 413/12
C07D 249/08
US Classification:

5142362, 544106, 544111, 544132, 5482622, 5482672, 5142312, 5142358, 514383
Abstract:

The present invention provides a triazole compound of the following formula: a prodrug thereof or a pharmaceutically acceptable salt thereof. The above-mentioned triazole compound is useful as a therapeutic drug for the treatment of diabetes, obesity or metabolic syndrome.

Substituted Pyrazolo[3,4-D]Pyrimidines As Ack-1 And Lck Inhibitors
view source
US Patent:

7763624, Jul 27, 2010
Filed:

Aug 18, 2006
Appl. No.:

11/506381
Inventors:

John L. Buchanan - Newton MA, US
William H. Buckner - Kittery ME, US
Mario G. Cardozo - San Francisco CA, US
Erin F. DiMauro - Cambridge MA, US
Jiasheng Fu - Foster City CA, US
Xiaolin Hao - Foster City CA, US
Xian Yun Jiao - San Mateo CA, US
Frank Kayser - San Francisco CA, US
David J. Kopecky - San Francisco CA, US
Craig E. Masse - Cambridge MA, US
Susan A. Tomlinson - Cambridge MA, US
Ryan White - Somerville MA, US
Xiaotian Zhu - Newton MA, US
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

C07D 487/04
A61K 31/519
A61K 31/496
A61P 35/00
C07D 231/56
A61K 31/416
US Classification:

5142621, 544262, 544 61, 544118, 5142285, 5142345, 51425216, 514407, 5483621
Abstract:

The present invention relates to compounds of Formula I.

Triazole Compounds And Uses Related Thereto
view source
US Patent:

8153631, Apr 10, 2012
Filed:

Nov 19, 2009
Appl. No.:

12/621922
Inventors:

Jay P. Powers - Pacifica CA, US
Mario G. Cardozo - San Francisco CA, US
Hiroyuki Goto - Takatsuki, JP
Kazuhito Harada - Osaka, JP
Katsuaki Imamura - Tokyo, JP
Makoto Kakutani - Takatsuki, JP
Isamu Matsuda - Tokyo, JP
Yasuhiro Ohe - Tokyo, JP
Shinji Yata - Tokyo, JP
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

A61K 31/4196
A61K 31/5377
C07D 413/12
C07D 249/08
US Classification:

5142362, 544106, 544111, 544132, 5482622, 5482672, 5142312, 514383
Abstract:

The present invention provides a triazole compound of the following formula:.

Glucocorticoid Mimetics, Methods Of Making Them, Pharmaceutical Compositions, And Thereof
view source
US Patent:

8212040, Jul 3, 2012
Filed:

Apr 25, 2006
Appl. No.:

11/410408
Inventors:

Younes Bekkali - Danbury CT, US
Rajashehar Betageri - Bethel CT, US
Mario G. Cardozo - San Francisco CA, US
Thomas A. Gilmore - Salem MA, US
Christian Hanke Justus Joachim Harcken - New Milford CT, US
Thomas Martin Kirrane - Danbury CT, US
Daniel Kuzmich - Danbury CT, US
John Robert Proudfoot - Newtown CT, US
Doris Riether - New York NY, US
Hidenori Takahashi - LaGrangeville NY, US
David S. Thomson - Ridgefield CT, US
Ji Wang - Amherst MA, US
Renee M. Zindell - New Milford CT, US
Hossein Razavi - Danbury CT, US
Assignee:

Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
International Classification:

C07D 471/02
A61K 31/44
US Classification:

546113, 514300
Abstract:

Compounds of Formula (IA).

Glucocorticoid Mimetics, Methods Of Making Them, Pharmaceutical Compositions, And Uses Thereof
view source
US Patent:

7268152, Sep 11, 2007
Filed:

Mar 21, 2003
Appl. No.:

10/394157
Inventors:

Younes Bekkali - Danbury CT, US
Mario G. Cardozo - San Francisco CA, US
Christian Hanke Justus Joachim Harcken - New Milford CT, US
Thomas M. Kirrane - Southbury CT, US
Daniel Kuzmich - Danbury CT, US
John Robert Proudfoot - Newtown CT, US
Hossein Razavi - Danbury CT, US
Hidenori Takahashi - LaGrangeville NY, US
David S. Thomson - Ridgefield CT, US
Ji Wang - Danbury CT, US
Renee Zindell - Danbury CT, US
Assignee:

Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
International Classification:

C07D 213/57
A61K 31/44
US Classification:

514357, 514408, 514517, 514519, 514651, 546330, 546334, 548566, 558418, 564355
Abstract:

Compounds of Formula (IA) and Formula (IB).